Coagulation Factor VIIa, recombinant is a coagulation factor indicated for: Treatment of bleeding episodes and perioperative management in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann?s thrombasthenia with refractoriness to platelet transfusions, with or without antibodies to platelets
This report aims to provide a comprehensive presentation of the global market for Recombinant Activated Coagulation Factor VII, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Activated Coagulation Factor VII. This report contains market size and forecasts of Recombinant Activated Coagulation Factor VII in global, including the following market information:
Global Recombinant Activated Coagulation Factor VII Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Activated Coagulation Factor VII Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Recombinant Activated Coagulation Factor VII companies in 2022 (%)
The global Recombinant Activated Coagulation Factor VII market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Vial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Recombinant Activated Coagulation Factor VII include Novo Nordisk, LFB SA HEMA Biologics and AryoGen Pharmed, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Activated Coagulation Factor VII manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Activated Coagulation Factor VII Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, by Type, 2022 (%)
Vial
Prefilled Syringe
Global Recombinant Activated Coagulation Factor VII Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, by Application, 2022 (%)
Hemophilia A
Hemophilia B
Other
Global Recombinant Activated Coagulation Factor VII Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Recombinant Activated Coagulation Factor VII Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Activated Coagulation Factor VII revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Activated Coagulation Factor VII revenues share in global market, 2022 (%)
Key companies Recombinant Activated Coagulation Factor VII sales in global market, 2018-2023 (Estimated), (Units)
Key companies Recombinant Activated Coagulation Factor VII sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Activated Coagulation Factor VII, market overview.
Chapter 2: Global Recombinant Activated Coagulation Factor VII market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Activated Coagulation Factor VII manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Activated Coagulation Factor VII in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Activated Coagulation Factor VII capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Activated Coagulation Factor VII Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Activated Coagulation Factor VII Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Activated Coagulation Factor VII Overall Market Size
2.1 Global Recombinant Activated Coagulation Factor VII Market Size: 2022 VS 2029
2.2 Global Recombinant Activated Coagulation Factor VII Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Recombinant Activated Coagulation Factor VII Sales: 2018-2029
3 Company Landscape
3.1 Top Recombinant Activated Coagulation Factor VII Players in Global Market
3.2 Top Global Recombinant Activated Coagulation Factor VII Companies Ranked by Revenue
3.3 Global Recombinant Activated Coagulation Factor VII Revenue by Companies
3.4 Global Recombinant Activated Coagulation Factor VII Sales by Companies
3.5 Global Recombinant Activated Coagulation Factor VII Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Activated Coagulation Factor VII Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Activated Coagulation Factor VII Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Activated Coagulation Factor VII Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Activated Coagulation Factor VII Market Size Markets, 2022 & 2029
4.1.2 Vial
4.1.3 Prefilled Syringe
4.2 By Type - Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
4.2.1 By Type - Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Activated Coagulation Factor VII Revenue, 2024-2029
4.2.3 By Type - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
4.3 By Type - Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
4.3.1 By Type - Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
4.3.2 By Type - Global Recombinant Activated Coagulation Factor VII Sales, 2024-2029
4.3.3 By Type - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
4.4 By Type - Global Recombinant Activated Coagulation Factor VII Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Activated Coagulation Factor VII Market Size, 2022 & 2029
5.1.2 Hemophilia A
5.1.3 Hemophilia B
5.1.4 Other
5.2 By Application - Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
5.2.1 By Application - Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Activated Coagulation Factor VII Revenue, 2024-2029
5.2.3 By Application - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
5.3 By Application - Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
5.3.1 By Application - Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
5.3.2 By Application - Global Recombinant Activated Coagulation Factor VII Sales, 2024-2029
5.3.3 By Application - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
5.4 By Application - Global Recombinant Activated Coagulation Factor VII Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Recombinant Activated Coagulation Factor VII Market Size, 2022 & 2029
6.2 By Region - Global Recombinant Activated Coagulation Factor VII Revenue & Forecasts
6.2.1 By Region - Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Activated Coagulation Factor VII Revenue, 2024-2029
6.2.3 By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
6.3 By Region - Global Recombinant Activated Coagulation Factor VII Sales & Forecasts
6.3.1 By Region - Global Recombinant Activated Coagulation Factor VII Sales, 2018-2023
6.3.2 By Region - Global Recombinant Activated Coagulation Factor VII Sales, 2024-2029
6.3.3 By Region - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.4.2 By Country - North America Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.4.3 US Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.4.4 Canada Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.4.5 Mexico Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.5.2 By Country - Europe Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.5.3 Germany Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.4 France Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.5 U.K. Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.6 Italy Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.7 Russia Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.8 Nordic Countries Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.5.9 Benelux Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.6.2 By Region - Asia Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.6.3 China Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.4 Japan Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.5 South Korea Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.6 Southeast Asia Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.6.7 India Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.7.2 By Country - South America Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.7.3 Brazil Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.7.4 Argentina Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, 2018-2029
6.8.3 Turkey Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8.4 Israel Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8.5 Saudi Arabia Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
6.8.6 UAE Recombinant Activated Coagulation Factor VII Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Summary
7.1.2 Novo Nordisk Business Overview
7.1.3 Novo Nordisk Recombinant Activated Coagulation Factor VII Major Product Offerings
7.1.4 Novo Nordisk Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk Key News & Latest Developments
7.2 LFB SA HEMA Biologics
7.2.1 LFB SA HEMA Biologics Company Summary
7.2.2 LFB SA HEMA Biologics Business Overview
7.2.3 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Major Product Offerings
7.2.4 LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.2.5 LFB SA HEMA Biologics Key News & Latest Developments
7.3 AryoGen Pharmed
7.3.1 AryoGen Pharmed Company Summary
7.3.2 AryoGen Pharmed Business Overview
7.3.3 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Major Product Offerings
7.3.4 AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales and Revenue in Global (2018-2023)
7.3.5 AryoGen Pharmed Key News & Latest Developments
8 Global Recombinant Activated Coagulation Factor VII Production Capacity, Analysis
8.1 Global Recombinant Activated Coagulation Factor VII Production Capacity, 2018-2029
8.2 Recombinant Activated Coagulation Factor VII Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Activated Coagulation Factor VII Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Activated Coagulation Factor VII Supply Chain Analysis
10.1 Recombinant Activated Coagulation Factor VII Industry Value Chain
10.2 Recombinant Activated Coagulation Factor VII Upstream Market
10.3 Recombinant Activated Coagulation Factor VII Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Activated Coagulation Factor VII Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Activated Coagulation Factor VII in Global Market
Table 2. Top Recombinant Activated Coagulation Factor VII Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Activated Coagulation Factor VII Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Activated Coagulation Factor VII Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Activated Coagulation Factor VII Sales by Companies, (Units), 2018-2023
Table 6. Global Recombinant Activated Coagulation Factor VII Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Activated Coagulation Factor VII Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Activated Coagulation Factor VII Product Type
Table 9. List of Global Tier 1 Recombinant Activated Coagulation Factor VII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Activated Coagulation Factor VII Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 15. By Type - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2024-2029
Table 16. By Application ? Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 20. By Application - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2024-2029
Table 21. By Region ? Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Activated Coagulation Factor VII Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2018-2023
Table 25. By Region - Global Recombinant Activated Coagulation Factor VII Sales (Units), 2024-2029
Table 26. By Country - North America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 29. By Country - North America Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 30. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 33. By Country - Europe Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 34. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 37. By Region - Asia Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 38. By Country - South America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 41. By Country - South America Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales, (Units), 2024-2029
Table 46. Novo Nordisk Company Summary
Table 47. Novo Nordisk Recombinant Activated Coagulation Factor VII Product Offerings
Table 48. Novo Nordisk Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novo Nordisk Key News & Latest Developments
Table 50. LFB SA HEMA Biologics Company Summary
Table 51. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Product Offerings
Table 52. LFB SA HEMA Biologics Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. LFB SA HEMA Biologics Key News & Latest Developments
Table 54. AryoGen Pharmed Company Summary
Table 55. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Product Offerings
Table 56. AryoGen Pharmed Recombinant Activated Coagulation Factor VII Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. AryoGen Pharmed Key News & Latest Developments
Table 58. Recombinant Activated Coagulation Factor VII Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 59. Global Recombinant Activated Coagulation Factor VII Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Recombinant Activated Coagulation Factor VII Production by Region, 2018-2023 (Units)
Table 61. Global Recombinant Activated Coagulation Factor VII Production by Region, 2024-2029 (Units)
Table 62. Recombinant Activated Coagulation Factor VII Market Opportunities & Trends in Global Market
Table 63. Recombinant Activated Coagulation Factor VII Market Drivers in Global Market
Table 64. Recombinant Activated Coagulation Factor VII Market Restraints in Global Market
Table 65. Recombinant Activated Coagulation Factor VII Raw Materials
Table 66. Recombinant Activated Coagulation Factor VII Raw Materials Suppliers in Global Market
Table 67. Typical Recombinant Activated Coagulation Factor VII Downstream
Table 68. Recombinant Activated Coagulation Factor VII Downstream Clients in Global Market
Table 69. Recombinant Activated Coagulation Factor VII Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Activated Coagulation Factor VII Segment by Type in 2022
Figure 2. Recombinant Activated Coagulation Factor VII Segment by Application in 2022
Figure 3. Global Recombinant Activated Coagulation Factor VII Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Activated Coagulation Factor VII Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Recombinant Activated Coagulation Factor VII Revenue, 2018-2029 (US$, Mn)
Figure 7. Recombinant Activated Coagulation Factor VII Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Activated Coagulation Factor VII Revenue in 2022
Figure 9. By Type - Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 11. By Type - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 12. By Type - Global Recombinant Activated Coagulation Factor VII Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 15. By Application - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 16. By Application - Global Recombinant Activated Coagulation Factor VII Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 20. By Region - Global Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 21. By Country - North America Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 22. By Country - North America Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 23. US Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 28. Germany Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 29. France Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 37. China Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 41. India Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 43. By Country - South America Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 44. Brazil Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Recombinant Activated Coagulation Factor VII Sales Market Share, 2018-2029
Figure 48. Turkey Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Recombinant Activated Coagulation Factor VII Revenue, (US$, Mn), 2018-2029
Figure 52. Global Recombinant Activated Coagulation Factor VII Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Recombinant Activated Coagulation Factor VII by Region, 2022 VS 2029
Figure 54. Recombinant Activated Coagulation Factor VII Industry Value Chain
Figure 55. Marketing Channels
